JSKN033

· Jiangsu Alphamab Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for JSKN033, covering 2025-01-13 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer [Phase 2]